Catch Knome on NOVA

Untitled2 Catch Knome on NOVAOn Wednesday, March 28th, Knome appeared on a special episode of NOVA, Cracking Your Genetic Code.

In the show, we help describe how the interpretation of human genomes is helping to solve medical mysteries and revolutionize personal healthcare.

“Insights from our own DNA will soon help each of us understand and manage the distinctive health risks we face.  Our genomes will thus take their place alongside family history, face-to-face visits, and lab tests, as cornerstones of clinical care.”  Dr. Pearson explains, “NOVA brings us a thoughtful glimpse of the challenges and promise of this coming era of genomically personalized medicine.”

The episode is available online. Check it out if you have the chance—it’s very well done.


Did you know February 29th is Rare Disease Day?


Screen Shot 2012 02 29 at 12.36.11 PM 350x331 Did you know February 29th is Rare Disease Day?

This year marks the fifth annual Rare Disease Day. According to the National Organization for Rare Disorders (NORD), rare diseases affect 30 million Americans. NORD is partnering with the NIH and major health organizations around the world to raise international awareness for this health challenge.

Rare Disease Day brings to light the importance of genetic research and the tools Knome provides to help develop diagnostics and treatments to better the lives of those affected by rare diseases and disorders.

February 29th was chosen based on the rarity of the date, Rare Disease Day is more commonly observed on February 28th!

Find out how you can get involved: http://rarediseaseday.us/


Knome Appoints Martin Tolar as Chief Executive Officer

Expands management team as company pursues new growth opportunities

CAMBRIDGE, MA – January 9, 2012 – Knome, Inc., the human genome interpretation company, today announced that it has appointed Martin Tolar, MD, PhD, as the company’s Chief Executive Officer. In addition, Knome has expanded the management team as the company pursues new growth opportunities to interpret and apply genomic information across the healthcare community—including academic researchers, drug companies, physicians, and consumers. Continue reading